Atherothrombosis and high-risk plaque: part I: evolving concepts.
暂无分享,去创建一个
Zahi A Fayad | Valentin Fuster | Roberto Corti | V. Fuster | Z. Fayad | J. Badimón | P. Moreno | R. Corti | Juan J Badimon | Pedro R Moreno
[1] V. Fuster,et al. Coronary plaque disruption. , 1995, Circulation.
[2] Bernd Ohnesorge,et al. Reproducibility and accuracy of coronary calcium measurements with multi-detector row versus electron-beam CT. , 2002, Radiology.
[3] F. Fowkes,et al. The Epidemiology of Peripheral Arterial Disease , 1993 .
[4] F. Kolodgie,et al. Intraplaque hemorrhage and progression of coronary atheroma , 2004 .
[5] David Zurakowski,et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Eidt,et al. Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.
[7] G. Camejo. Hydrolytic enzymes released from resident macrophages and located in the intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[8] V. Fuster,et al. Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.
[9] R. Detrano,et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. , 2004, JAMA.
[10] Peter Libby,et al. Atherosclerosis: the new view. , 2002, Scientific American.
[11] J F Martin,et al. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[12] Samin K. Sharma,et al. Identification of active tissue factor in human coronary atheroma. , 1996, Circulation.
[13] D. Lomas,et al. High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty , 2000, Heart.
[14] R. Virmani,et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.
[15] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[16] G. Palareti,et al. The cardiovascular risk burden of intermittent claudication , 2002 .
[17] P. Libby. Molecular bases of the acute coronary syndromes. , 1995, Circulation.
[18] Paolo Raggi,et al. High coronary artery calcium scores pose an extremely elevated risk for hard events. , 2002, Journal of the American College of Cardiology.
[19] J. Danesh,et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis , 2001, The Lancet.
[20] J. Ware,et al. Too many vessels? Not enough? The wrong kind? The VEGF debate continues. , 2001, Nature Medicine.
[21] Andrew C Larson,et al. Self‐gated cardiac cine MRI , 2004, Magnetic resonance in medicine.
[22] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[23] B. H. Shah,et al. Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophy , 2004, Trends in Endocrinology & Metabolism.
[24] Mario J. Garcia,et al. ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. , 2005, Journal of the American College of Cardiology.
[25] René M. Botnar,et al. Age and Sex Distribution of Subclinical Aortic Atherosclerosis: A Magnetic Resonance Imaging Examination of the Framingham Heart Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[26] D. Ku,et al. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.
[27] David W. Banner,et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.
[28] S. Alper,et al. Hemodynamic shear stress and its role in atherosclerosis. , 1999, JAMA.
[29] V. Fuster,et al. 831-1 Ruptured diabetic atherosclerotic plaques have more inflammation and neovascularization than ruptured plaques from patients without diabetes , 2004 .
[30] M. Reiser,et al. Coronary artery calcium: absolute quantification in nonenhanced and contrast-enhanced multi-detector row CT studies. , 2002, Radiology.
[31] R. Virmani,et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.
[32] V. Fuster,et al. Technology Insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging , 2004, Nature Clinical Practice Cardiovascular Medicine.
[33] Paul M. Ridker,et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.
[34] S. Chung,et al. Marked Hippocampal Neuronal Damage without Motor Deficits after Mild Concussive‐like Brain Injury in Apolipoprotein E‐deficient Mice , 2000, Annals of the New York Academy of Sciences.
[35] J. Sluijter,et al. In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions , 2002, Circulation.
[36] P. Greenland,et al. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. , 2003, The New England journal of medicine.
[37] Robertag . Williams,et al. 25th Bethesda Conference: Future Personnel Needs for Cardiovascular Health Care. November 15-16, 1993. , 1994, Journal of the American College of Cardiology.
[38] B. Gersh,et al. Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease , 1994 .
[39] V. Fuster,et al. Computed Tomography and Magnetic Resonance Imaging for Noninvasive Coronary Angiography and Plaque Imaging: Current and Potential Future Concepts , 2002, Circulation.
[40] V. Fuster,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. , 1995, Circulation.
[41] A. Tedgui,et al. Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[42] A. Naim,et al. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases. , 2004, Clinical and investigative medicine. Medecine clinique et experimentale.
[43] R. Langer,et al. The Epidemiology of Peripheral Arterial Disease: Importance of Identifying the Population at Risk , 1997, Vascular medicine.
[44] Eric M Isselbacher,et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. , 2004, Circulation.
[45] P. Libby,et al. Induction of Endothelial-Leukocyte Interaction by Interferon-γ Requires Coactivation of Nuclear Factor-κB , 2001 .
[46] S. Kaul,et al. Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II , 2001, Circulation.
[47] V. Fuster,et al. Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability , 2002, Circulation.
[48] P. Frenette. Locking a leukocyte integrin with statins. , 2001, The New England journal of medicine.
[49] R. Prescott,et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.
[50] T. Shigematsu,et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[51] S. Chierchia,et al. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. , 1978, The New England journal of medicine.
[52] A. Tedgui,et al. Current perspective on the role of apoptosis in atherothrombotic disease. , 2001, Circulation research.
[53] A. Barger,et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.
[54] P. Vallance,et al. Endogenous factors involved in regulation of tone of arterial vasa vasorum: implications for conduit vessel physiology. , 2000, Cardiovascular research.
[55] V. Fuster,et al. Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions: A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging , 2001, Circulation.
[56] A. Lee,et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.
[57] K. Ouriel. Peripheral arterial disease , 2001, The Lancet.
[58] F. Eberli,et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. , 2001, Journal of the American College of Cardiology.
[59] P. D. de Feyter,et al. Noninvasive visualization of atherosclerotic plaque with electron beam and multislice spiral computed tomography. , 2003, Journal of interventional cardiology.
[60] N. Flavahan,et al. Activated Monocytes Induce Smooth Muscle Cell Death: Role of Macrophage Colony-Stimulating Factor and Cell Contact , 2002, Circulation.
[61] P. Libby,et al. CD40 Signaling and Plaque Instability , 2001, Circulation research.
[62] Raymond J Kim,et al. Frontiers in cardiovascular magnetic resonance. , 2005, Circulation.
[63] K R Maravilla,et al. Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRI: A Case-Control Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[64] R. Kitsis,et al. Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes. , 2004, Biochemical and biophysical research communications.
[65] M J Davies,et al. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. , 1996, Circulation.
[66] K. Williams,et al. The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[67] D. Singer,et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. , 2000, JAMA.
[68] W D Wagner,et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[69] Z. Galis,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[70] A. Schmermund,et al. Non-invasive computed tomographic coronary angiography: the end of the beginning. , 2005, European heart journal.
[71] T. Callister,et al. Use of electron beam tomography data to develop models for prediction of hard coronary events. , 2001, American heart journal.
[72] V. Fuster,et al. Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. , 2000, Journal of the American College of Cardiology.
[73] V. Fuster,et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.
[74] Samin K. Sharma,et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. , 2000, Circulation.
[75] V. Fuster,et al. Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. , 2000, The American journal of cardiology.
[76] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[77] D. Harrison,et al. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.
[78] E. Bolson,et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.
[79] W. Edwards,et al. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. , 1994, The Journal of clinical investigation.
[80] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[81] P. Meraj,et al. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. , 1999, Journal of the American College of Cardiology.
[82] J. Witztum,et al. Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.
[83] E L Ritman,et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.
[84] E. Unanue,et al. Activated macrophages induce vascular proliferation , 1977, Nature.
[85] M. Marcus,et al. Role of vasa vasorum in nourishment of the aorta. , 1979, Blood vessels.
[86] J. Borén,et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.
[87] C. Napoli,et al. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis , 2004, Current diabetes reports.
[88] G. Clagett,et al. Antithrombotic therapy in peripheral arterial occlusive disease. , 1992, Chest.
[89] J P Ornato,et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. , 2000, JAMA.
[90] R. Kriwacki,et al. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. , 1999, Journal of molecular biology.
[91] Juan J. Badimon,et al. Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.
[92] M. Tsan,et al. Cytokine function of heat shock proteins. , 2004, American journal of physiology. Cell physiology.
[93] Zahi A Fayad,et al. Parallel and nonparallel simultaneous multislice black‐blood double inversion recovery techniques for vessel wall imaging , 2004, Journal of magnetic resonance imaging : JMRI.
[94] V. Fuster,et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. , 1997, Circulation.
[95] S. Kaul,et al. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice. , 1998, Circulation.
[96] Renu Virmani,et al. Morphological Predictors of Arterial Remodeling in Coronary Atherosclerosis , 2002, Circulation.
[97] Siamon Gordon,et al. Pattern Recognition Receptors Doubling Up for the Innate Immune Response , 2002, Cell.
[98] V. Fuster,et al. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. , 2000, Atherosclerosis.
[99] D. Clement. A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .
[100] R. Rosenberg,et al. Regulation of Vascular Bed–Specific Prothrombotic Potential , 2001, Circulation research.
[101] P. Shah,et al. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. , 2001, Circulation.
[102] Amir Lerman,et al. Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[103] René M. Botnar,et al. Free‐breathing 3D coronary MRA: The impact of “Isotropic” image resolution , 2000, Journal of magnetic resonance imaging : JMRI.
[104] V. Fuster,et al. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.
[105] S Glagov,et al. Nature of Species Differences in the Medial Distribution of Aortic Vasa Vasorum in Mammals , 1967, Circulation research.
[106] K. Kugiyama,et al. Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. , 1999, Journal of the American College of Cardiology.
[107] V. Fuster,et al. Caspase-3 and Tissue Factor Expression in Lipid-Rich Plaque Macrophages: Evidence for Apoptosis as Link Between Inflammation and Atherothrombosis , 2004, Circulation.
[108] René M. Botnar,et al. Three-Dimensional Black-Blood Cardiac Magnetic Resonance Coronary Vessel Wall Imaging Detects Positive Arterial Remodeling in Patients With Nonsignificant Coronary Artery Disease , 2002, Circulation.
[109] V. Fuster,et al. Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture , 1994, Circulation.
[110] Gieri Cathomas,et al. Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.
[111] Jan Nilsson,et al. Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I , 2001, Circulation.
[112] Richard T. Lee,et al. Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.
[113] T. Latifi,et al. Diet-induced Diabetes Activates an Osteogenic Gene Regulatory Program in the Aortas of Low Density Lipoprotein Receptor-deficient Mice* , 1998, The Journal of Biological Chemistry.
[114] M. Rosenfeld. Leukocyte recruitment into developing atherosclerotic lesions: the complex interaction between multiple molecules keeps getting more complex. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[115] P. Touboul,et al. Serum Elastase Activity, Serum Elastase Inhibitors, and Occurrence of Carotid Atherosclerotic Plaques: The Etude sur le Vieillissement Artériel (EVA) Study , 2002, Circulation.
[116] P. Wilson,et al. 34th Bethesda Conference: Task force #4--How do we select patients for atherosclerosis imaging? , 2003, Journal of the American College of Cardiology.
[117] V. Fuster,et al. Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.
[118] Pedro A. Lemos,et al. Reliable Noninvasive Coronary Angiography With Fast Submillimeter Multislice Spiral Computed Tomography , 2002, Circulation.
[119] L. Badimón,et al. A Sudden Increase in Plasma Epinephrine Levels Transiently Enhances Platelet Deposition on Severely Damaged Arterial Wall , 1999, Thrombosis and Haemostasis.
[120] P. Ridker,et al. Novel clinical markers of vascular wall inflammation. , 2001, Circulation research.
[121] V F Froelicher,et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. , 2000, Journal of the American College of Cardiology.
[122] A. Chait,et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease☆ , 2002 .
[123] W. Koenig,et al. C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[124] K. Grant,et al. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. , 1995, The American journal of pathology.
[125] E. Ritman,et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular Research.
[126] Andrew C Larson,et al. Coronary MRA with 3D undersampled projection reconstruction TrueFISP , 2002, Magnetic resonance in medicine.
[127] R. Virmani,et al. 34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques? , 2003, Journal of the American College of Cardiology.
[128] M. Reiser,et al. Multidetector-row computed tomography of the coronary arteries: predictive value and quantitative assessment of non-calcified vessel-wall changes , 2003, European Radiology.
[129] K. Triantafilou,et al. Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. , 2004, Biochemical Society transactions.
[130] A. Hofman,et al. Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of Atherosclerosis: The Rotterdam Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[131] J. Loscalzo,et al. Nitric oxide insufficiency and atherothrombosis , 2004, Histochemistry and Cell Biology.
[132] V. Fuster,et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. , 1999, Circulation.
[133] S. Achenbach,et al. Detection of Calcified and Noncalcified Coronary Atherosclerotic Plaque by Contrast-Enhanced, Submillimeter Multidetector Spiral Computed Tomography: A Segment-Based Comparison With Intravascular Ultrasound , 2003, Circulation.
[134] G Pasterkamp,et al. Arterial Remodeling: Mechanisms and Clinical Implications , 2000 .
[135] B Hillen,et al. Localizing role of hemodynamics in atherosclerosis in several human vertebrobasilar junction geometries. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[136] R. Munford. Statins and the acute-phase response. , 2001, The New England journal of medicine.
[137] J. Gladman,et al. Direct magnetic resonance imaging of carotid artery thrombus in acute stroke , 1999, The Lancet.
[138] S M Schwartz,et al. The intima. Soil for atherosclerosis and restenosis. , 1995, Circulation research.
[139] Allen J. Taylor,et al. Executive summary—can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? , 2003 .
[140] R. Virmani,et al. When neoangiogenesis ricochets. , 1998, American heart journal.
[141] P. Libby,et al. Soluble CD40L and Cardiovascular Risk in Women , 2001, Circulation.
[142] K. Sueishi,et al. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. , 1995, Human pathology.
[143] P. Shah,et al. Immunomodulation of atherosclerosis: implications for vaccine development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[144] Williams Jk,et al. The vasa vasorum of the arteries , 1996 .
[145] V. Fuster,et al. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.
[146] J. Parodi,et al. Carotid rupture and intraplaque hemorrhage: immunophenotype and role of cells involved. , 1998, American heart journal.
[147] Cheuk Y. Tang,et al. Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast‐weighted magnetic resonance images , 2004, Magnetic resonance in medicine.
[148] C. Claussen,et al. Noninvasive evaluation of the prevalence of noncalcified atherosclerotic plaques by multi-slice detector computed tomography: results of a pilot study. , 2003, International journal of cardiology.
[149] Luca Cozzi,et al. Effects of Percutaneous Transluminal Angioplasty and Endovascular Brachytherapy on Vascular Remodeling of Human Femoropopliteal Artery by Noninvasive Magnetic Resonance Imaging , 2004, Circulation.
[150] V. Hombach,et al. C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis , 2001, Circulation.
[151] V. Fuster,et al. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. , 1994, Circulation.
[152] D. Rader,et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. , 1999, Mayo Clinic proceedings.
[153] R. Ross,et al. The pathogenesis of atherosclerosis (second of two parts). , 1976, The New England journal of medicine.
[154] B. G. Brown,et al. Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[155] T. Callister,et al. Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.
[156] V. Fuster,et al. Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. , 1994, Circulation.
[157] P. Shah,et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. , 1994, Circulation.
[158] D. Heistad,et al. Vasa Vasorum in Atherosclerotic Coronary Arteries: Responses to Vasoactive Stimuli and Regression of Atherosclerosis , 1988, Circulation research.
[159] S. Kaul,et al. High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice: Potential Implications for Acute Plaque Stabilization , 2001, Circulation.
[160] A. Schmermund,et al. Unstable coronary plaque and its relation to coronary calcium. , 2001, Circulation.
[161] Dwight G Nishimura,et al. Spiral magnetic resonance coronary angiography with rapid real-time localization. , 2003, Journal of the American College of Cardiology.
[162] M. Budoff,et al. Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions. , 2003, American heart journal.
[163] S. Blankenberg,et al. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. , 2002, The American journal of cardiology.
[164] Konstantin Nikolaou,et al. Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT , 2003, European Radiology.
[165] J. Freyssinet,et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.
[166] Z. Fayad,et al. Serial Studies of Mouse Atherosclerosis by In Vivo Magnetic Resonance Imaging Detect Lesion Regression After Correction of Dyslipidemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[167] V. Salomaa,et al. Hemostatic Factors as Predictors of Coronary Events and Total Mortality: The FINRISK ’92 Hemostasis Study , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[168] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[169] G. Raff,et al. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. , 2005, Journal of the American College of Cardiology.
[170] Chun Yuan,et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. , 2002 .
[171] G. Hansson. Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis, thrombosis, and vascular biology.
[172] Werner Moshage,et al. Detection of Coronary Artery Stenoses by Contrast-Enhanced, Retrospectively Electrocardiographically-Gated, Multislice Spiral Computed Tomography , 2001, Circulation.
[173] S. Schwartz,et al. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. , 1994, Circulation research.
[174] S. Schwartz,et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[175] H. C. Stary,et al. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. , 2001, The American journal of cardiology.
[176] O. Kemmotsu,et al. Significant Correlations between Tissue Factor and Thrombin Markers in Trauma and Septic Patients with Disseminated Intravascular Coagulation , 1998, Thrombosis and Haemostasis.
[177] K. Kugiyama,et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. , 1999, Circulation.
[178] E. Gabazza,et al. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease , 1999, American journal of hematology.
[179] H. C. Stary. Composition and classification of human atherosclerotic lesions , 2005, Virchows Archiv A.
[180] Matthijs Oudkerk,et al. Coronary angiography with multi-slice computed tomography , 2001, The Lancet.
[181] M. Gimbrone,et al. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. , 1997, The Journal of clinical investigation.
[182] G Laub,et al. 3D magnetization‐prepared true‐FISP: A new technique for imaging coronary arteries , 2001, Magnetic resonance in medicine.
[183] V. Fuster,et al. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. , 2001, Journal of the American College of Cardiology.
[184] C. Kunsch,et al. Oxidative stress as a regulator of gene expression in the vasculature. , 1999, Circulation research.
[185] P. Libby,et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.
[186] D. Steinberg,et al. Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis? , 2002, Circulation.
[187] B. Hedblad,et al. Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis , 1993, The Lancet.
[188] V. Fuster,et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. , 1994, Journal of the American College of Cardiology.
[189] Samin K. Sharma,et al. 831-6 Atherosclerotic plaque inflammation is associated with increased intima-medial neovascularization , 2004 .
[190] R. Hynes,et al. The combined role of P- and E-selectins in atherosclerosis. , 1998, The Journal of clinical investigation.
[191] A. Nicolaides,et al. Investigation of chronic venous insufficiency: A consensus statement (France, March 5-9, 1997). , 2000, Circulation.
[192] Samin K. Sharma,et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. , 1996, Circulation.
[193] I. Kullo,et al. Vulnerable Plaque: Pathobiology and Clinical Implications , 1998, Annals of Internal Medicine.
[194] R. Morin,et al. Radiation dose in computed tomography of the heart. , 2003, Circulation.
[195] Irwin Feuerstein,et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. , 2005, Journal of the American College of Cardiology.
[196] M. Ishida,et al. Shear Stress-mediated Extracellular Signal-regulated Kinase Activation Is Regulated by Sodium in Endothelial Cells , 1999, The Journal of Biological Chemistry.
[197] J. Partridge,et al. Coronary calcification score: the coronary-risk impact factor , 2004, The Lancet.
[198] Anne L. Martel,et al. Prevalence of Complicated Carotid Atheroma as Detected by Magnetic Resonance Direct Thrombus Imaging in Patients With Suspected Carotid Artery Stenosis and Previous Acute Cerebral Ischemia , 2003, Circulation.
[199] H. Kato. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[200] Paul Schoenhagen,et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[201] P. Kaufmann,et al. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. , 1997, Circulation.
[202] C. Claussen,et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in patients with angiographically proven coronary artery disease. , 2004, Journal of the American College of Cardiology.
[203] A Daugherty,et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.
[204] R. Ross,et al. The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.
[205] P. Quax,et al. Toll-Like Receptor 4 Is Involved in Outward Arterial Remodeling , 2004, Circulation.
[206] Mario J. Garcia,et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance. , 2005, Circulation.
[207] S L Diamond,et al. Definitions in biorheology: cell aggregation and cell adhesion in flow. Recommendation of the Scientific Subcommittee on Biorheology of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. , 2002, Thrombosis and haemostasis.
[208] Elena Bonanno,et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. , 2004, JAMA.
[209] V. Fuster,et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. , 2000, Circulation.
[210] J. Isner,et al. Statin Therapy Accelerates Reendothelialization: A Novel Effect Involving Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells , 2002, Circulation.
[211] G. Miller. Hemostasis and cardiovascular risk. The British and European experience. , 1992, Archives of pathology & laboratory medicine.
[212] C. White,et al. Usefulness of multislice spiral computed tomography angiography for determination of coronary artery stenoses. , 2001, The American journal of cardiology.
[213] V. Fuster,et al. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. , 2000, Circulation.
[214] V. Fuster,et al. Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.
[215] Anne L. Martel,et al. Characterization of Complicated Carotid Plaque With Magnetic Resonance Direct Thrombus Imaging in Patients With Cerebral Ischemia , 2003, Circulation.
[216] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[217] V. Fuster,et al. Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.
[218] Antonio Colombo,et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. , 2004, European heart journal.
[219] Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. , 2001, The New England journal of medicine.
[220] H. Figulla,et al. Collateral Function in Chronic Total Coronary Occlusions Is Related to Regional Myocardial Function and Duration of Occlusion , 2001, Circulation.
[221] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[222] A. Zwinderman,et al. Detection of Vein Graft Disease Using High-Resolution Magnetic Resonance Angiography , 2002, Circulation.
[223] A. Schmermund,et al. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease. , 2002, The American journal of cardiology.
[224] Rita F. Redberg. Coronary Artery Calcium Should We Rely on This Surrogate Marker , 2006 .
[225] Z. Fayad,et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[226] W. Bautz,et al. Detection of Coronary Artery Stenoses With Thin-Slice Multi-Detector Row Spiral Computed Tomography and Multiplanar Reconstruction , 2003, Circulation.
[227] A. Comerota,et al. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. , 2001, The American journal of cardiology.
[228] V. Fuster,et al. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[229] I. Goldberg,et al. Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[230] Jerome F. Strauss,et al. The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.
[231] René M. Botnar,et al. Free-breathing 3D steady-state free precession coronary MR angiography with radial k-space sampling: comparison with cartesian k-space sampling and cartesian gradient-echo coronary MR angiography--pilot study. , 2004, Radiology.
[232] Y. Nemerson. Tissue factor and hemostasis. , 1988, Blood.
[233] L. Wilkins. New Investigator Awards , 2005 .
[234] M. Reilly,et al. Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo , 2003, Circulation.
[235] D. Tschoepe,et al. Platelet-leukocyte-cross-talk in diabetes mellitus. , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[236] J. Freyssinet,et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. , 1999, Blood.
[237] D. Levy,et al. C-Reactive Protein Is Associated With Subclinical Epicardial Coronary Calcification in Men and Women: The Framingham Heart Study , 2002, Circulation.
[238] R. Rutherford,et al. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.
[239] T. Callister,et al. Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial ☆ ☆☆ , 2001 .
[240] M A Konerding,et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.
[241] V. Fuster,et al. Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity , 2003, Circulation.
[242] K. Hirokawa,et al. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. , 1993, The Journal of clinical investigation.
[243] T. Edgington. So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control. , 2001, The American journal of pathology.
[244] V. Fuster,et al. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. , 1998, Circulation.
[245] B. Nordestgaard,et al. Dose-dependent suppression of transplant arteriosclerosis in aorta-allografted, cholesterol-clamped rabbits. Suppression not eliminated by the cholesterol-raising effect of cyclosporine. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[246] Chun Yuan,et al. Identification of Fibrous Cap Rupture With Magnetic Resonance Imaging Is Highly Associated With Recent Transient Ischemic Attack or Stroke , 2002, Circulation.
[247] V. Fuster,et al. MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[248] V. Deshpande,et al. Three‐dimensional true‐FISP imaging of the coronary arteries: Improved contrast with T2‐preparation , 2002, Journal of magnetic resonance imaging : JMRI.
[249] V. Fuster,et al. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. , 1998, Circulation.
[250] A. Whittemore. Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.
[251] R. Virmani,et al. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. , 1996, Journal of vascular surgery.
[252] G. Pasterkamp,et al. Role of Toll‐like receptor 4 in the initiation and progression of atherosclerotic disease , 2004, European journal of clinical investigation.
[253] Stephan Achenbach,et al. Clinical utility of computed tomography and magnetic resonance techniques for noninvasive coronary angiography. , 2003, Journal of the American College of Cardiology.
[254] H. C. Stary,et al. Natural history and histological classification of atherosclerotic lesions: an update. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[255] J. Schaper,et al. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. , 2004, Journal of the American College of Cardiology.
[256] P. Barter,et al. Antiinflammatory Properties of HDL , 2004 .
[257] R. Nerem. Vascular fluid mechanics, the arterial wall, and atherosclerosis. , 1992, Journal of biomechanical engineering.
[258] J. Beesley,et al. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a 'neoadventitia'. , 1994, Atherosclerosis.
[259] M. Davies,et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.
[260] L. Ignarro. Experimental evidences of nitric oxide‐dependent vasodilatory activity of nebivolol, a third‐generation β‐blocker , 2004, Blood pressure. Supplement.
[261] C Ahn,et al. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. , 1994, The American journal of cardiology.
[262] Valentin Fuster,et al. Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences , 2001, Annals of Internal Medicine.
[263] M. Prince,et al. Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. , 1996, AJR. American journal of roentgenology.
[264] J. Badimón,et al. Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. , 1989, The Journal of clinical investigation.
[265] K. Yokote,et al. Enhanced Expression of Osteopontin by High Glucose: Involvement of Osteopontin in Diabetic Macroangiopathy a , 2000, Annals of the New York Academy of Sciences.
[266] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[267] B. Gersh,et al. Unrecognized Myocardial Infarction , 2001, Annals of Internal Medicine.
[268] James T. Willerson,et al. Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.
[269] D. Tschoepe,et al. Platelet activation in diabetic cardiovascular autonomic neuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[270] Alan Daugherty,et al. T lymphocytes in atherosclerosis: the yin-yang of Th1 and Th2 influence on lesion formation. , 2002, Circulation research.
[271] P. Barter. HDL: a recipe for longevity. , 2004, Atherosclerosis. Supplements.
[272] L. Chambless,et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Atherosclerosis.
[273] H. Du,et al. Lysosomal Enzymes Are Released From Cultured Human Macrophages, Hydrolyze LDL In Vitro, and Are Present Extracellularly in Human Atherosclerotic Lesions , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[274] M. Criqui,et al. Patterns and Risk Factors for Systemic Calcified Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[275] P. V. Van Schil,et al. Possible mechanisms of collar-induced intimal thickening. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[276] A. Tajik,et al. Novel risk factors for atherosclerosis. , 2000, Mayo Clinic proceedings.
[277] Zahi A Fayad,et al. Rapid extended coverage simultaneous multisection black-blood vessel wall MR imaging. , 2004, Radiology.
[278] D. Tanné,et al. Soluble intercellular adhesion molecule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. , 2002, Journal of the American College of Cardiology.
[279] C. Zarins,et al. Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.
[280] W. Aird,et al. Vascular-bed--specific hemostasis and hypercoagulable states. , 1999, The New England journal of medicine.
[281] S. Shaw,et al. Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. , 1998, Circulation research.
[282] K. Engelmann,et al. Techniques for the detection of coronary atherosclerosis: multi-detector row CT coronary angiography. , 2002, Radiology.
[283] P. McBride,et al. The significance of lower extremity peripheral arterial disease , 2002, Clinical cardiology.
[284] Frederick J Schoen,et al. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. , 2004, The Journal of heart valve disease.
[285] S. Schwartz,et al. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[286] M. A. Sellers,et al. Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1998, The American journal of cardiology.
[287] R. Virmani,et al. Elevated C-Reactive Protein Values and Atherosclerosis in Sudden Coronary Death: Association With Different Pathologies , 2002, Circulation.
[288] J L Witztum,et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.
[289] P. Kovanen,et al. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.
[290] F. Neumann,et al. Proteolysis of Tissue Factor Pathway Inhibitor-1 by Thrombolysis in Acute Myocardial Infarction , 2002, Circulation.
[291] V. Fuster,et al. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.
[292] J. Badimón,et al. Blood-borne tissue factor: another view of thrombosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[293] P. Shah. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis? , 2002, Circulation.